Omnicell, Inc. OMCL
33.66
0.67
2.03%
as of 25 Sep
- Market cap
- $1.5B
- P/E
- 39.5×
Follow OMCL
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
70.81 | 1,132.50 | 75.86 | 48.85 |
P/S ratio |
1.18 | 1.76 | 1.23 | 1.52 | |
P/FCF ratio |
14.79 | 30.02 | 15.47 | 14.94 | |
P/Operating CF |
49.06 | 68.60 | 27.76 | 27.72 | |
P/B ratio |
1.14 | 1.69 | 1.20 | 1.47 | |
Price to Tangible BV |
4.46 | 6.43 | 4.27 | 4.81 | |
EV/Sales |
1.32 | 1.88 | 1.32 | 1.56 | |
EV/EBITDA |
14.44 | 23.59 | 13.32 | 13.45 | |
EV/Operating CF |
10.11 | 17.50 | 10.37 | 10.72 | |
EV/FCF |
16.52 | 32.12 | 16.52 | 15.34 | |
Quick Ratio |
0.93 | 0.87 | 1.01 | 1.16 | |
Current Ratio |
1.44 | 1.43 | 1.50 | 1.64 | |
Net Debt/EBITDA |
(0.42) | (1.27) | (1.88) | (2.31) | |
Debt/Assets |
8.59% | 8.49% | 8.38% | 8.41% | |
Debt/Equity |
0.14 | 0.14 | 0.13 | 0.13 | |
Asset Turnover |
0.55 | 0.58 | 0.59 | 0.60 | |
Operating CF/Net income |
5.18 | (14.98) | 4.80 | 2.81 | |
Capex/Depreciation |
(0.65) | (0.54) | (0.76) | (0.59) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
7.73% | 7.18% | 6.94% | 6.50% | |
Selling, General and Administrative Expense of Revenue |
32.91% | 34.19% | 32.91% | 32.09% | |
Intangible Assets out of Total Assets |
0.47 | 0.46 | 0.45 | 0.45 | |
Share Based Compensation of Revenue |
3.61% | 3.81% | 3.07% | 3.91% | |
Graham Net Nets |
(0.05) | (0.03) | (0.02) | 0.01 | |
Graham Number |
16.11 | 4.91 | 16.57 | 23.27 | |
Earnings Yield |
1.41% | 0.09% | 1.32% | 2.05% | |
Free Cash Flow Yield |
6.76% | 3.33% | 6.47% | 6.69% | |
Revenue per Share |
6.82 | 6.83 | 6.84 | 6.85 | |
Operating CF per Share |
0.62 | 0.66 | 1.20 | 1.50 | |
Capex per Share |
(0.31) | (0.26) | (0.35) | (0.27) | |
Free Cash Flow per Share |
0.31 | 0.40 | 0.85 | 1.22 | |
Cash per Share |
3.95 | 4.28 | 5.28 | 6.41 | |
Shareholders Equity per Share |
26.81 | 26.80 | 27.73 | 28.32 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
26.81 | 26.80 | 27.73 | 28.32 | |
Free Cash Flow |
13.99 | 18.36 | 38.63 | 55.78 | |
Working Capital |
203.03 | 203.46 | 239.25 | 287.95 | |
Capital Expenditures |
(14.28) | (11.99) | (15.87) | (12.53) | |
Net Current Asset Value |
(68.07) | (62.84) | (25.17) | 28.13 | |
EV/EBIT |
90.35 | 431.81 | 48.06 | 33.55 | |
Capex to Sales |
0.05 | 0.04 | 0.05 | 0.04 | |
Net Profit Margin |
1.76% | (0.65%) | 3.67% | 7.78% | |
Price to Operating Income |
80.90 | 403.54 | 44.98 | 32.67 | |
| Other line items | |||||
Average Receivables |
248.74 | 236.63 | 250.70 | 229.87 | |
Average Payables |
55.15 | 47.89 | 55.81 | 56.10 | |
Average Inventory |
101.24 | 94.78 | 95.17 | 101.25 | |
Average Assets |
2,126.09 | 2,047.84 | 2,077.79 | 2,072.18 | |
Average Common Equity |
1,226.12 | 1,237.56 | 1,256.87 | 1,277.61 |
Columns are period end dates